Matspin Tablet contains a combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg, formulated to manage and prevent motion sickness, vertigo, and related vestibular disorders. Cinnarizine is an antihistaminic agent with calcium channel blocking properties that helps reduce vestibular stimulation and improve blood flow in the inner ear, thereby alleviating symptoms such as dizziness and nausea. Dimenhydrinate, an antihistamine with anticholinergic effects, acts centrally to suppress the vomiting reflex and reduce nausea associated with motion sickness. The synergistic action of these two active ingredients provides effective relief from symptoms including nausea, vomiting, dizziness, and imbalance caused by motion sickness or vestibular disturbances. Matspin Tablet is indicated for use in conditions such as seasickness, travel sickness, labyrinthitis, and Ménière’s disease. It should be used under medical supervision, particularly in patients with a history of hypersensitivity to antihistamines, glaucoma, or prostatic hypertrophy. Common side effects may include drowsiness, dry mouth, and gastrointestinal discomfort. Caution is advised when driving or operating machinery due to potential sedation. Dosage and duration of treatment should be individualized based on clinical response and patient tolerance.